Table 4.
Age‐standardised 30‐day, 90‐day, 1‐year and 5‐year relative survival rates stratified by T stage for patients with localised RCC treated with nephrectomy
| Relative survival rate | Year | AAPC, % | P | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |||
| T1 (n = 5828) | |||||||||||||
| 30‐day % (95% CI) | 99.1 (91.9–99.9) | 99.7 (93.4–100) | 99.8 (93.3–100) | 99.2 (96.9–99.8) | 100 (–) | 99.6 (97.3–100) | 99.6 (98.2–99.9) | 100 (–) | 99.5 (98.5–99.8) | 99.6 (98.7–99.9) | 99.7 (98.9–99.9) | 0.03 | 0.35 |
| 90‐day % (95% CI) | 97.9 (91.8–99.5) | 99.6 (90.1–100) | 99.7 (86.2–100) | 98.9 (96.2–99.8) | 100 (–) | 99.7 (93.0–100) | 99.6 (97.2–99.9) | 100 (–) | 99.1 (97.8–99.6) | 99.5 (98.3–99.9) | 99.7 (98.4–99.9) | 0.1 | 0.17 |
| 1‐year % (95% CI) | 99.5 (11.8–100) | 99.7 (1.6–100) | 97.7 (93.2–99.2) | 98.7 (93.8–99.7) | 99.7 (46.2–100) | 98.7 (95.1–99.7) | 98.2 (95.5–99.3) | 99.6 (91.5–100) | 99.1 (96.8–99.7) | 98.9 (97.0–99.6) | 99.3 (97.4–99.8) | <0.01 | 0.96 |
| 5‐year % (95% CI) | 92.6 (79.6–97.5) | 92.7 (83.8–96.8) | 92.6 (84.9–96.5) | 95.4 (87.6–98.3) | 98.7 (77.5–99.9) | 92.6 (87.1–95.8) | 92.6 (87.9–95.5) | 97.0 (91.8–98.9) | 94.2 (90.7–96.4) | 96.4 (92.8–98.2) | 97.2 (93.9–98.7) | 0.4 | 0.10 |
| T2 (n = 2416) | |||||||||||||
| 30‐day % (95% CI) | 100 (–) | 98.7 (94.0–99.7) | 97.8 (93.8–99.2) | 99.3 (96.0–99.9) | 100 (–) | 100 (–) | 99.1 (95.7–99.8) | 99.0 (96.3–99.7) | 99.8 (93.9–100) | 99.0 (96.5–99.7) | 98.3 (96.3–99.2) | –0.03 | 0.74 |
| 90‐day % (95% CI) | 100 (–) | 99.1 (91.4–99.9) | 96.9 (92.3–98.8) | 99.2 (94.8–99.9) | 100 (–) | 99.5 (92.3–100) | 99.4 (93.5–99.9) | 98.1 (94.8–99.3) | 99.0 (96.0–99.8) | 98.6 (95.7–99.6) | 97.5 (95.2–98.7) | –0.1 | 0.32 |
| 1‐year % (95% CI) | 96.1 (86.9–98.9) | 96.3 (88.7–98.8) | 92.0 (85.9–95.6) | 94.6 (88.3–97.5) | 99.0 (86.2–99.9) | 95.9 (91.1–98.1) | 97.5 (92.4–99.2) | 96.0 (91.6–98.1) | 96.0 (92.1–98.0) | 96.3 (92.4–98.2) | 97.2 (94.1–98.7) | 0.2 | 0.33 |
| 5‐year % (95% CI) | 86.5 (73.3–93.5) | 74.4 (63.1–82.7) | 75.9 (66.6–82.9) | 85.0 (75.1–91.1) | 81.6 (71.9–88.2) | 88.0 (79.9–92.9) | 88.2 (80.2–93.1) | 85.6 (78.3–90.5) | 82.9 (76.3–87.8) | 88.5 (81.7–92.9) | 86.0 (81.7–92.9) | 0.9 | 0.10 |
| T3 (n = 4320) and T4 (n = 158) | |||||||||||||
| 30‐day % (95% CI) | 97.3 (93.3–98.9) | 96.3 (92.4–98.3) | 99.0 (96.2–99.7) | 98.1 (95.8–99.2) | 96.1 (93.2–97.8) | 96.3 (93.8–97.8) | 98.7 (96.5–99.5) | 98.6 (96.9–99.3) | 99.2 (98.1–99.7) | 98.5 (97.2–99.2) | 98.9 (97.8–99.5) | 0.2 | 0.09 |
| 90‐day % (95% CI) | 95.4 (90.6–97.8) | 93.2 (88.4–96.1) | 95.5 (91.8–97.6) | 97.5 (94.8–98.8) | 92.9 (89.4–95.2) | 95.3 (92.5–97.1) | 97.3 (94.5–98.7) | 96.9 (94.7–98.2) | 97.3 (95.5–98.4) | 96.6 (94.9–97.8) | 97.9 (96.5–98.8) | 0.3 | 0.05 |
| 1‐year % (95% CI) | 83.9 (76.8–89.0) | 80.3 (73.5–85.5) | 86.1 (80.6–90.1) | 88.3 (83.8–91.7) | 82.4 (77.5–86.4) | 86.1 (81.8–89.5) | 86.6 (82.0–90.0) | 87.6 (83.9–90.5) | 88.9 (85.8–91.4) | 89.2 (86.4–91.5) | 91.8 (89.4–93.7) | 0.9 | <0.01 |
| 5‐year % (95% CI) | 59.0 (49.5–67.4) | 51.2 (42.8–58.9) | 65.9 (58.1–72.5) | 60.6 (54.0–66.6) | 59.9 (53.3–65.8) | 67.6 (61.6–72.8) | 66.7 (60.2–72.3) | 66.3 (61.0–71.1) | 63.8 (59.1–68.1) | 68.6 (64.2–72.5) | 71.6 (67.6–75.1) | 2.1 | 0.01 |